Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RA2159 | EGF | 100 | ng/mL | 1 | IL-10 | 49.0 | 60 | ||||
| RA2159 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 1 | IL-10 | 55.0 | 55 | |
| RA2159 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IL-10 | 51.5 | 54 | |
| RA2159 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IL-10 | 44.0 | 68 | |
| RA2159 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IL-10 | 73.0 | 65 | |
| RA2159 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 1 | IL-10 | 50.5 | 52 | |
| RA2159 | JNK-IN-11 | 0.3 | uM | 1 | IL-10 | 44.5 | 66 | ||||
| N2586 | EGF | 100 | ng/mL | 1 | IL-10 | 76.0 | 59 | ||||
| N2586 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 1 | IL-10 | 72.0 | 49 | |
| N2586 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IL-10 | 66.0 | 51 | |
| N2586 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IL-10 | 57.0 | 46 | |
| N2586 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | IL-10 | 68.0 | 51 | |
| N2586 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 1 | IL-10 | 66.5 | 36 | |
| N2586 | JNK-IN-11 | 0.3 | uM | 1 | IL-10 | 70.0 | 53 | ||||
| RA2159 | IGF-I | 100 | ug/mL | 1 | IL-10 | 56.0 | 58 | ||||
| RA2159 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 1 | IL-10 | 49.0 | 50 | |
| RA2159 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | IL-10 | 48.0 | 47 | |
| RA2159 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | IL-10 | 59.0 | 57 | |
| RA2159 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | IL-10 | 64.0 | 81 | |
| RA2159 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 1 | IL-10 | 59.0 | 69 | |
| RA2159 | 1 | IL-10 | 57.5 | 60 | |||||||
| N2586 | IGF-I | 100 | ug/mL | 1 | IL-10 | 59.5 | 54 | ||||
| N2586 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 1 | IL-10 | 72.0 | 44 | |
| N2586 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | IL-10 | 65.0 | 61 | |
| N2586 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | IL-10 | 65.0 | 53 |